In the United States at least, physicians are generally convinced that when the evidence is in, screening for prostate cancer with the prostate-specific antigen (PSA) test will be shown to do more good than harm. Support for that opinion can be found in physicians’ personal decisions about PSA testing: as of 2000, 78% of male primary care physicians and 95% of male urologists 50 years and older in a national sample reported having had a PSA test.1
Barry MJ. The PSA Conundrum. Arch Intern Med. 2006;166(1):7–8. doi:10.1001/archinte.166.1.7
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: